Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
There was no observation related to data integrity reported
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Subscribe To Our Newsletter & Stay Updated
